These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12925158)

  • 21. International collaborative study to establish immunoglobulin (anti-D test) BRP batch 1.
    Thorpe SJ; Fox B; Heath A; Behr-Gross ME; Virata ML; Yu MW
    Pharmeuropa Bio; 2006 Nov; 2006(1):49-56. PubMed ID: 17270131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe Hemolytic Anemia Following Intravenous Immunoglobulin in an Infant With Kawasaki Disease.
    Tocan V; Inaba A; Kurano T; Sonoda M; Soebijanto K; Nakayama H
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):e100-e102. PubMed ID: 27879540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion-Transmitted Injuries Surveillance System (Ontario).
    Batarfi K; Liu Y; Nixon J; Webert KE; John MS; Karunakaran M; Alhomsi N; Park JJ; Heddle NM
    Vox Sang; 2023 Sep; 118(9):753-762. PubMed ID: 37592865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.
    Lawlor E; Power J; Garson J; Yap P; Davidson F; Columb G; Smith D; Pomeroy L; O'Riordan J; Simmonds P; Tedder R
    Vox Sang; 1999; 76(3):138-43. PubMed ID: 10341327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immune globulin-related hemolysis: comparing two different methods for case assessment.
    Taylor E; Vu D; Legare C; Keene D
    Transfusion; 2015 Jul; 55 Suppl 2():S23-7. PubMed ID: 26174894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible mechanisms for intravenous immunoglobulin-associated hemolysis: clues obtained from review of clinical case reports.
    Padmore R
    Transfusion; 2015 Jul; 55 Suppl 2():S59-64. PubMed ID: 26174898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
    Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
    J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of intravenous immunoglobulin (2 g/kg totally) and single doses of anti-D immunoglobulin at 50 μg/kg, 75 μg/kg in newly diagnosed children with idiopathic thrombocytopenic purpura: Ankara hospital experience.
    Alioglu B; Ercan S; Tapci AE; Zengin T; Yazarli E; Dallar Y
    Blood Coagul Fibrinolysis; 2013 Jul; 24(5):505-9. PubMed ID: 23470649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The viral safety of intravenous immune globulin.
    Yap PL
    Clin Exp Immunol; 1996 May; 104 Suppl 1():35-42. PubMed ID: 8625542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment.
    Gerber S; Gaida A; Spiegl N; Wymann S; Antunes AM; Menyawi IE; Zurbriggen B; Hubsch A; Imboden M
    BioDrugs; 2016 Oct; 30(5):441-451. PubMed ID: 27646589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemolytic events associated with intravenous immune globulin therapy: a qualitative analysis of 263 cases reported to four manufacturers between 2003 and 2012.
    Berg R; Shebl A; Kimber MC; Abraham M; Schreiber GB
    Transfusion; 2015 Jul; 55 Suppl 2():S36-46. PubMed ID: 26174896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International collaborative study of assay of anti-D (anti-Rh) immunoglobulin.
    Bangham DR; Kirkwood TB; Wybrow G; Hughes-Jones NC; Gunson HH
    Br J Haematol; 1978 Mar; 38(3):407-23. PubMed ID: 416846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain.
    Echevarría JM; León P; Domingo CJ; López JA; Elola C; Madurga M; Salmerón F; Yap PL; Daub J; Simmonds P
    Transfusion; 1996 Aug; 36(8):725-30. PubMed ID: 8780668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An optimized microplate-based method to evaluate complement-dependent hemolysis mediated by intravenous immunoglobulins (IVIG).
    Wang Y; Khalenkov A; Scott DE
    Biologicals; 2022 Jul; 78():1-9. PubMed ID: 35842374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An enzyme-linked immunosorbent assay for the quantitative determination of anti-D in plasma samples and immunoglobulin preparations.
    Hirvonen M; Tervonen S; Pirkola A; Sievers G
    Vox Sang; 1995; 69(4):341-6. PubMed ID: 8751304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
    Cooper N; Heddle NM; Haas M; Reid ME; Lesser ML; Fleit HB; Woloski BM; Bussel JB
    Br J Haematol; 2004 Feb; 124(4):511-8. PubMed ID: 14984503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes.
    Michelis FV; Branch DR; Scovell I; Bloch E; Pendergrast J; Lipton JH; Cserti-Gazdewich CM
    Transfusion; 2014 Mar; 54(3):681-90. PubMed ID: 23829192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.